Hinge Health Inc (HNGE) PT Raised to $70 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts HNGE Hot Sheet
Price: $119.20 -1.38%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Barclays analyst Saket Kalia raised the price target on Hinge Health Inc (NYSE: HNGE) to $70.00 (from $62.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Hinge Health Inc (HNGE) PT Raised to $135 at Stifel
- Adient (ADNT) PT Lowered to $22 at UBS
- Peabody Energy (BTU) PT Lowered to $26 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
